Neuroprosthetic effect of peroneal nerve stimulation in multiple sclerosis: a preliminary study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19236994.
- Also identified by DOI 10.1016/j.apmr.2008.10.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the neuroprosthetic effect of a peroneal nerve stimulator on tasks of functional ambulation in multiple sclerosis (MS). A single point-in-time assessment of functional ambulation tasks under the conditions of no device and peroneal nerve stimulator. Outpatient academic medical center. Participants (N=11) with diagnosis of MS (>6mo), dorsiflexion weakness, and prior usage of an ankle-foot orthosis. Surface peroneal nerve stimulator for ambulation. Timed 25-foot Walk portion of the MS Functional Composite; Floor, Carpet, Up and Go, Obstacle, and Stair components of the Modified Emory Functional Ambulation Profile. Peroneal nerve stimulator-Stair performance was significantly enhanced (P=.05) versus no device, and statistical significance was approached for peroneal nerve stimulator-Obstacles (P=.09) versus no device. There were no significant differences between peroneal nerve stimulator and no device conditions in the remaining outcome measures. The neuroprosthetic effect of the peroneal nerve stimulator is modest relative to no device in the performance of specific functional tasks of ambulation in MS gait. A longitudinal, controlled trial is needed to show effectiveness.
Medical subject headings
- Multiple Sclerosis
- Peroneal Nerve
- Transcutaneous Electric Nerve Stimulation